TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year debt growth rate

Percentile
P29
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-1.55%
Q3 2025-1.11%
Q2 2025-0.35%
Q1 2025-0.35%
Q4 20247.77%
Q3 2024-4.57%
Q2 20243.19%
Q1 2024-0.72%
Q4 20236.27%
Q3 2023-0.86%
Q2 20232.84%
Q1 2023-0.78%
Q4 2022153.64%
Q3 2022546.70%
Q2 2022-7.16%
Q1 2022-6.57%
Q4 2021-5.74%
Q3 2021-5.53%
Q2 2021-5.08%
Q1 2021-3.83%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%
Q4 20190.00%